Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective.
about
Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Screening for intracranial ane ...... ney disease is cost-effective.
@en
Screening for intracranial ane ...... ney disease is cost-effective.
@nl
type
label
Screening for intracranial ane ...... ney disease is cost-effective.
@en
Screening for intracranial ane ...... ney disease is cost-effective.
@nl
prefLabel
Screening for intracranial ane ...... ney disease is cost-effective.
@en
Screening for intracranial ane ...... ney disease is cost-effective.
@nl
P2093
P1433
P1476
Screening for intracranial ane ...... ney disease is cost-effective.
@en
P2093
Bertrand Knebelmann
Denis Trystram
Dominique Joly
François Nataf
Jean-Pierre Grünfeld
Marie Fouchard
P356
10.1016/J.KINT.2017.08.016
P407
P577
2017-10-20T00:00:00Z